article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law Blog

The government asserted additional allegations that are outside our scope. Prescribing Red Flags The government alleged that from at least 2017 to April 2021 Defendants knowingly filled controlled substance prescriptions “that raised obvious ’red flags’ of potential abuse or diversion.” Zarzamora Press Release. Complaint ¶ 55.

article thumbnail

The Most Engaging Decision You’ll Read All Year – Five Stars

FDA Law Blog

Koblitz — You know a court decision is going to be worth reading when the judges compare FDA’s regulatory governance of flavored e-cigarettes to a Shakespearean gaslighting. Let’s just say, the smackdown—er, decision—eviscerates FDA’s approach to regulating flavored e-cigarettes. By David B. Clissold & Sara W.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Teva case, that the statutory provisions governing patent infringement, specifically induced infringement, do not address carve-outs. Instead, it was GSK who erred in omitting the post-MI language from the use code. The catch is, as we have learned from the GSK v.

IT 52
article thumbnail

The Promise and Pitfalls of AI in Medicine: Guest Bob Wachter

GeriPal

I remember walking through San Francisco Airport with Bob, we just happened to be there at similar times, and saying, “Eric and I are thinking about starting a blog.” I think a lot of back office function, predicting ER loads and OR loads to do better scheduling of staff. I think we’re smarter about it than we were.

IT 139